European Heart Journal · 2016 · 285 citations · 34 references
MedicineCardiologyClinical SciencesCardiovascular PharmacotherapyClinical CardiologyInterventional CardiologyAnticoagulant TherapyAnticoagulation TherapyAntiplatelet TherapyAntithrombotic TherapyStrokeThrombosisOutcome MeasuresPost-stroke AnticoagulationPost-stroke Antithrombotic TherapyStroke Embolism
AIMS: The relationship between outcomes and time after diagnosis for patients with non-valvular atrial fibrillation (NVAF) is poorly defined, especially beyond the first year. METHODS AND RESULTS: -VASc score was 3.3 (1.6); 60.8% of patients were prescribed anticoagulant therapy with/without antiplatelet (AP) therapy, 27.4% AP monotherapy, and 11.8% no antithrombotic therapy. At 2-year follow-up, all-cause mortality, stroke/SE, and major bleeding had occurred at a rate (95% confidence interval) of 3.83 (3.62; 4.05), 1.25 (1.13; 1.38), and 0.70 (0.62; 0.81) per 100 person-years, respectively. Rates for all three major events were highest during the first 4 months. Congestive heart failure, acute coronary syndromes, sudden/unwitnessed death, malignancy, respiratory failure, and infection/sepsis accounted for 65% of all known causes of death and strokes for <10%. Anticoagulant treatment was associated with a 35% lower risk of death. CONCLUSION: The most frequent of the three major outcome measures was death, whose most common causes are not known to be significantly influenced by anticoagulation. This suggests that a more comprehensive approach to the management of NVAF may be needed to improve outcome. This could include, in addition to anticoagulation, interventions targeting modifiable, cause-specific risk factors for death. CLINICAL TRIAL REGISTRATION: http://www.clinicaltrials.gov. Unique identifier: NCT01090362.
34
Prevalence of Diagnosed Atrial Fibrillation in Adults
Alan S. Go, Elaine M. Hylek, Kathleen A. Phillips et al. · JAMA · 2001 · 6.2K citations
Impact of Atrial Fibrillation on the Risk of Death
Emelia J. Benjamin, Philip A. Wolf, Ralph B. D’Agostino et al. · Circulation · 1998 · 4.6K citations
Medicine, Cardiology, Aging +16
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
A. John Camm, Gregory Y.H. Lip, Raffaele De Caterina et al. · EP Europace · 2012 · 3.8K citations · Full text